LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Enliven Therapeutics (NASDAQ: ELVN)

Follow NASDAQ:ELVN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
04/07/2025
Sell
$17.81
3,756
$67K
319,554
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
04/07/2025
Sell
$18.29
2,763
$51K
316,791
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
04/07/2025
Sell
$19.27
148
$3K
316,643
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
03/27/2025
Sell
$2.48
3,250
$8K
128,556
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
03/27/2025
Buy
$2.48
3,250
$8K
26,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
03/27/2025
Sell
$21.33
3,250
$69K
23,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
03/24/2025
Sell
$2.48
1,000
$2K
131,806
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
03/24/2025
Buy
$2.48
1,000
$2K
24,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
03/24/2025
Sell
$22.50
1,000
$23K
23,000
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
03/19/2025
Sell
$20.61
12,500
$258K
1.00M
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
03/17/2025
Sell
$20.83
12,500
$260K
990,392
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
03/07/2025
Sell
$21.44
6,667
$143K
323,310
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
03/04/2025
Sell
$2.48
10,000
$25K
132,806
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
03/04/2025
Buy
$2.48
10,000
$25K
23,000
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
02/27/2025
Sell
$2.48
3,250
$8K
142,806
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
02/27/2025
Buy
$2.48
3,250
$8K
16,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
02/27/2025
Sell
$20.41
3,250
$66K
13,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous